RecruitingNot ApplicableNCT07119229

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

A Multicenter, Prospective Trial Evaluating the Safety and Efficacy of the Implantable Artificial Bronchus (IAB) in Adults Suffering From Severe Emphysema

Sponsor

Pulmair Medical, Inc.

Enrollment

60 participants

Start Date

Mar 25, 2026

Study Type

INTERVENTIONAL

Conditions

Emphysema or COPD Emphysema COPD

Summary

A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Implantable Artificial Bronchus for people with copd, emphysema, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEImplantable Artificial Bronchus

The Implantable Artificial Bronchus (IAB) is a tapered, flexible and fenestrated polymer-based airway stent that is implanted bronchoscopically using a proprietary delivery system into diseased lungs of patients with emphysema.